APP and Alzheimer disease: Notably, GPR158 expression was inversely correlated with β-secretase (BACE1) activity in AD brain samples, indicating that lower GPR158 levels are associated with increased BACE1 activity, which could in turn enhance Aβ production from Amyloid Precursor Protein (APP).